Cargando…

Dystrophic calcinosis in a patient with overlap syndrome (scleroderma and rheumatoid arthritis) treated by leflunomide: A case report

RATIONALE: Dystrophic calcinosis occurs in chronically damaged tissue in patients with complicated autoimmune diseases. The therapeutic options are limited, and the treatment response rate is variable. Here, we describe a rare case of dystrophic calcinosis treated with leflunomide in a patient with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Sang Yeob, Lee, Sung Won, Chung, Won Tae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393103/ https://www.ncbi.nlm.nih.gov/pubmed/30461645 http://dx.doi.org/10.1097/MD.0000000000013319

Ejemplares similares

Clinical Image: Calcinosis cutis universalis in a patient with polymyositis/scleroderma overlap syndrome
por: Carbonell, Katie, et al.
Publicado: (2021)

Multiple supramassetric dystrophic calcinosis
por: Mohiuddin, Syed Ahmed, et al.
Publicado: (2012)

Acro-osteolysis & calcinosis in scleroderma
por: Cherian, Sujith V., et al.
Publicado: (2016)

Clinical Images: dystrophic calcinosis cutis
por: Alhassan, Eaman, et al.
Publicado: (2023)

Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate
por: Lee, Sang-Won, et al.
Publicado: (2012)

The Effect of Leflunomide on Cold and Vibratory Sensation in Patients with Rheumatoid Arthritis
por: Kim, Hyung Kuk, et al.
Publicado: (2012)

Discoid lupus erythematosus with dystrophic calcinosis cutis
por: Korekawa, Ayumi, et al.
Publicado: (2015)

Dystrophic Calcinosis Cutis in Systemic Lupus Erythematosus
por: Achebe, Ikechukwu, et al.
Publicado: (2020)

Elderly-onset calcinosis of hyperphosphataemic familial tumoural calcinosis/hyperostosis-hyperphosphataemia syndrome: the role of comorbid scleroderma
por: Iwasaki, Hiroaki
Publicado: (2023)

Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
por: Jones, Peter BB, et al.
Publicado: (2010)

Coexistence of Multiple Pulmonary Sclerosing Pneumocytoma and Scleroderma–Rheumatoid Arthritis Overlap Syndrome: A Case Report
por: Abalı, Hülya, et al.
Publicado: (2022)

Dystrophic calcinosis cutis in chronic venous disease of the lower limbs
por: Pacheco, Carolina Heil Arostegui, et al.
Publicado: (2022)

Dystrophic calcinosis cutis in a patient with cutaneous sarcoidosis in remission
por: Yoshikawa, Miyuki, et al.
Publicado: (2022)

Leflunomide-induced and paraneoplastic ulcers in a rheumatoid arthritis patient
por: Vittori, Michael R., et al.
Publicado: (2022)

Linear Scleroderma with Calcinosis and its Successful Treatment with Surgical Excision
por: Agarwal, Uma Shankar, et al.
Publicado: (2013)

Acro-osteolysis and calcinosis in patient with scleroderma: A case report
por: Choi, Wan-Sun, et al.
Publicado: (2017)

Brain abscess in a rheumatoid arthritis patient treated with leflunomide – A case presentation and review
por: Samara, Efthymia, et al.
Publicado: (2021)

Evaluation of efficacy of combination of methotrexate and hydroxychloroquine with leflunomide in active rheumatoid arthritis
por: Shashikumar, N.S., et al.
Publicado: (2010)

Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients
por: Hopkins, AM, et al.
Publicado: (2015)

Comparative Effectiveness of Tocilizumab with either Methotrexate or Leflunomide in the Treatment of Rheumatoid Arthritis
por: Narváez, Javier, et al.
Publicado: (2015)

Interleukin-18 in Brazilian Rheumatoid Arthritis Patients: Can Leflunomide Reduce It?
por: Gualberto Cardoso, Pablo Ramon, et al.
Publicado: (2021)

Combination of Methotrexate and Leflunomide Is Efficient and Safe for 60 Patients with Rheumatoid Arthritis
por: Chen, Fang, et al.
Publicado: (2022)

Dystrophic calcinosis cutis associated with systemic lupus erythematosus: a case report
por: Sousa, Filipa Costa, et al.
Publicado: (2021)

CREST Syndrome in Systemic Sclerosis Patients – Is Dystrophic Calcinosis a Key Element to a Positive Diagnosis?
por: Bobeica, Carmen, et al.
Publicado: (2022)

A Case Report of Successful Treatment of Recalcitrant Childhood Localized Scleroderma with Infliximab and Leflunomide
por: Ferguson, Ian D, et al.
Publicado: (2015)

Resolution of calcinosis using bisphosphonates in overlap syndrome – a case report
por: Platter, Mitchell, et al.
Publicado: (2021)

Hepatitis E infection in a patient with rheumatoid arthritis treated with leflunomide: A case report with emphasis on geoepidemiology
por: Carubbi, Francesco, et al.
Publicado: (2019)

Dermatomyositis with scleroderma-overlap syndrome and its anaesthetic implications
por: Yemul-Golhar, Shweta R, et al.
Publicado: (2011)

Tripterygium Glycosides Combined with Leflunomide for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Yang, Yi-Jing, et al.
Publicado: (2020)

The prognostic value of whole-genome DNA methylation in response to Leflunomide in patients with Rheumatoid Arthritis
por: Chen, Yulan, et al.
Publicado: (2023)

1. Early scleroderma overlap syndrome (pulmonary hypertension, ILD, polymyositis and inflammatory arthritis) and an unplanned pregnancy
por: Thorne, Iona, et al.
Publicado: (2017)

Shrinking lung syndrome in systemic lupus erythematosus-scleroderma overlap
por: Guleria, Vivek S., et al.
Publicado: (2014)

Leflunomide in the treatment of patients with early rheumatoid arthritis—results of a prospective non-interventional study
por: Kellner, Herbert, et al.
Publicado: (2010)

A case of pulmonary fibrosis associated with rheumatoid arthritis, scleroderma sine scleroderma and ANCA associated vasculitis
por: Anand, Amritpal Singh, et al.
Publicado: (2014)

Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis
por: Wiese, Michael D, et al.
Publicado: (2012)

Enhanced Lymphatic Uptake of Leflunomide Loaded Nanolipid Carrier via Chylomicron Formation for the Treatment of Rheumatoid Arthritis
por: Krishnan, Yadhu, et al.
Publicado: (2018)

Non-healing tongue ulcer in a rheumatoid arthritis patient medicated with leflunomide. An adverse drug event?
por: Kalogirou, Eleni-Marina, et al.
Publicado: (2017)

Leflunomide-Induced Immune-Mediated Necrotizing Myopathy in a Patient With Rheumatoid Arthritis: A Case Report
por: Salazar, Dylan Matthew, et al.
Publicado: (2023)

Palisaded Neutrophilic Granulomatous Dermatitis in a Patient with Systemic Sclerosis-Rheumatoid Arthritis Overlap Syndrome
por: Jung, Kyong-Hee, et al.
Publicado: (2017)

Diffuse alveolar damage in a patient with rheumatoid arthritis under prolonged leflunomide treatment: A Case Report and Literature Review
por: Keng, Li-Ta, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2oc07h34ut9ndtusfmucq69tvr